3 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amiloride in Nephrotic Syndrome Amiloride, Furosemide - Nephrotic Syndrome, Edema | Phase 3 | Terminated | University Hospital Tuebingen | 20 | 2020-06-08 | 2025-01-14 |
| Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome. Enoxaparin - Nephrotic Syndrome | Phase 2 / Phase 3 | Terminated | Military Institute od Medicine National Research Institute | 65 | 2015-10-01 | 2023-01-30 |
| Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome Rituximab, MMF - Frequent Relapsing Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome | Phase 3 | Terminated | Nationwide Children's Hospital | 3 | 2015-01-01 | 2019-03-26 |
Nephrotic Syndrome (3) · Edema (1) · Hypernatremia (1) · Venous Thromboembolism (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Thromboembolism (1) · Vascular Diseases (1)
Amiloride (1) · Enoxaparin (1) · Furosemide (1) · Rituximab (1)
Military Institute od Medicine National Research Institute (1) · Nationwide Children's Hospital (1) · University Hospital Tuebingen (1)
Germany (1) · Poland (1) · United States (1)
Anna Matyjek, MD, PhD (1) · Ferruh Artunc, Prof., MD (1) · Laurence Greenbaum, MD (1) · William Smoyer, MD (1)
2019 (1)